BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Mentice Inc. Sponsors Breakthrough Virtual Reality Medical Procedure At Euro-PCR


10/19/2005 5:11:32 PM

PARIS, France, May 27 /PRNewswire/ -- Mentice, together with Guidant Corporation and Paris Course on Revascularization (Euro-PCR), yesterday announced that for the first time during a live case transmission at the Euro-PCR, a carotid stenting procedure was rehearsed on a virtual-reality simulator before the actual procedure was performed on the patient. The training simulator uses technology developed by the Swedish company Mentice and provides realistic visual and tactile feedback. The virtual anatomy used in the rehearsal is created from a 3D scan of the patient's anatomy. "In several clinical studies it has been proven that our Procedicus(R) simulators, such as MIST and VIST, improved performance in the operating room. (1,2) With the unique procedure rehearsal capability and fidelity, demonstrated at the Euro-PCR, we can now advance the field of endovascular simulation to the next generation: Patient specific training and pre procedure planning and rehearsal", say Mr. Jonas Ohlsson, President of Mentice Corporation.

The live case transmission was scheduled for Wednesday, May 26, from 2 pm to 4.30 pm during the focus session "Carotid Stenting: Do Emboli Matter?" Dr. Lukas van Dijk, radiologist, and Dr. Johanna Hendriks, vascular surgeon, at the Erasmus Medical Center in Rotterdam, The Netherlands, performed both the virtual and actual procedures. Dr. Marc van Sambeek, vascular surgeon at the same hospital, moderated the focus session.

"Virtual Procedure Rehearsal brings several advantages, including anticipation of complications, better informed selection of tools and techniques to be used, and reduction of procedure time," said Dr. Van Sambeek. "We believe these advances will result in higher procedure success rates and in cost reductions.

Due to its revolutionary impact on training for interventional procedures, Mentice training simulators were integrated into the core curriculum of Euro-PCR. "The advantages of this innovative training tool are comparable to those of flight simulator training," said Prof. Marco of Clinique Pasteur in Toulouse and course director of Euro-PCR. "With this tool, a physician can become proficient at the procedure in a very short timeframe without the pressures of actual surgery. It is clear that in the future this type of training will become mandatory in the education of physicians."

About the Paris Course on Revascularization

The annual Paris Course on Revascularization, held May 25-28 in Paris, is focused on education and training of physicians who treat patients with cardiovascular diseases. Advanced education techniques and programs are of particular interest and value at the well-attended event. More information can be found at http://www.europcr.com/.

About Mentice

Mentice provides turnkey solutions such as Procedicus(R) VIST - including hardware, software and technical support - from entry-level skills acquisition to high-fidelity procedural training. With the Procedicus(R) products, Mentice focuses on the following minimally invasive surgery areas: endovascular intervention, laparoscopy and arthroscopy. For more information, visit http://www.mentice.com/.

Guidant's Commitment to Continuing Education

More than 6,000 participants have attended Guidant's Institute for Therapy Advancement in Brussels, Belgium, where physicians are provided with discussion forums and hands-on experience moderated by a faculty of independent clinical experts. The institute's programs aim to advance the standard of care and improve patient outcomes. Guidant opened a second Institute in Tokyo, Japan, and is constructing a third in St. Paul, Minnesota, USA.

About Guidant Corporation

Guidant Corporation pioneers lifesaving technology, giving an opportunity for better life today to millions of cardiac and vascular patients worldwide. The company, driven by a strong entrepreneurial culture of 12, 000 employees, develops, manufactures and markets a road array of products and services that enable less invasive care for some of life's most threatening medical conditions. For more information, visit http://www.guidant.com/.

References (for a complete list see http://www.mentice.com)/

1. Virtual reality training improves operating room performance: results of a randomized, doubleblinded study. Seymour NE, Gallagher AG et al. Ann Surg. 2002 Oct; 236(4):458-63.

2. Randomized clinical trial of virtual reality simulation for laparoscopic skills training. Grantcharov TP et al. Br. J. of Surg. 2004 Feb; 91 (2):146-50

Contact: Jonas Ohlsson, President, Mentice Corporation, +46-709-734792, email: Jonas.Ohlsson@mentice.com

Mentice Medical Simulation AB

CONTACT: Jonas Ohlsson, President, Mentice Corporation, +46-709-734792,email: Jonas.Ohlsson@mentice.com



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES